Key Takeaways
- • Crescent Capital Group LP priced Atlas Senior Loan Fund XXVIII ("Atlas 28"), a $406.9 million new-issue collateralized loan obligation, on October 29, 2026.
- • The deal attracted 20 distinct investors and will invest primarily in U.S. senior secured term loans, with select senior secured corporate bonds.
- • Atlas 28 is Crescent's second new-issue CLO of 2026 and the fourth issued through its CLO Equity Fund II, which closed in August.
- • Crescent cites market volatility in leveraged loans as an opportunity to selectively acquire assets at attractive prices.
- • Crescent reports $53 billion in assets under management as of September 30, 2026, and nearly $20 billion in CLOs issued and managed since 1992.
Summary
Crescent Capital Group LP, a Los Angeles-based alternative credit investment firm, announced the pricing of Atlas Senior Loan Fund XXVIII ("Atlas 28"), a $406.9 million new-issue collateralized loan obligation (CLO) priced on October 29, 2026. According to the company's Business Wire release, the transaction attracted 20 distinct investors and will invest primarily in U.S. senior secured term loans, along with select senior secured corporate bonds.
The deal is Crescent's second new-issue CLO of 2026 and the fourth issued through its CLO Equity Fund II, which closed in August. Nilesh Mandhare, Managing Director, Portfolio Manager and Head of CLO issuance business at Crescent, said the firm welcomed several new investors through the transaction. He attributed the outcome to volatility in the leveraged loan market, which gave the team opportunities to selectively acquire assets at attractive prices, and described the approach as disciplined and patient.
Crescent says it has more than 30 years of experience in the CLO market and has issued and managed just under $20 billion in CLOs since 1992 across multiple market cycles. The platform is supported by an integrated team in New York and Los Angeles with experience across leveraged loans, high-yield bonds and CLOs.
According to the release, Crescent is a global credit investment manager with $53 billion in assets under management as of September 30, 2026. The firm focuses on non-investment grade credit, including senior bank loans, high yield bonds, and private senior, unitranche and junior debt. It is headquartered in Los Angeles, has offices in New York, Boston, Chicago, London and Frankfurt, and employs over 235 people globally. Crescent is part of GreenOak, the global investment platform owned by Sun Life.
The deal is Crescent's second new-issue CLO of 2026 and the fourth issued through its CLO Equity Fund II, which closed in August. Nilesh Mandhare, Managing Director, Portfolio Manager and Head of CLO issuance business at Crescent, said the firm welcomed several new investors through the transaction. He attributed the outcome to volatility in the leveraged loan market, which gave the team opportunities to selectively acquire assets at attractive prices, and described the approach as disciplined and patient.
Crescent says it has more than 30 years of experience in the CLO market and has issued and managed just under $20 billion in CLOs since 1992 across multiple market cycles. The platform is supported by an integrated team in New York and Los Angeles with experience across leveraged loans, high-yield bonds and CLOs.
According to the release, Crescent is a global credit investment manager with $53 billion in assets under management as of September 30, 2026. The firm focuses on non-investment grade credit, including senior bank loans, high yield bonds, and private senior, unitranche and junior debt. It is headquartered in Los Angeles, has offices in New York, Boston, Chicago, London and Frankfurt, and employs over 235 people globally. Crescent is part of GreenOak, the global investment platform owned by Sun Life.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.